We are proud to again be selected as #1 by neurology patient organisations worldwide in PatientView’s Corporate Reputation survey. Our hope is to create a tomorrow where neurological conditions no longer limit human potential - to preserve what makes us who we are. Collaborating with patient communities at every stage of the R&D and care journey is critical to achieving this vision. Read more from some of our Neurology Leaders about what this recognition means! #AlzheimersDisease #WorldAlzheimersMonth
Info
Roche ist ein globales Unternehmen mit Vorreiterrolle in der Erforschung und Entwicklung von Medikamenten und Diagnostika und ist darauf fokussiert, Menschen durch wissenschaftlichen Fortschritt ein besseres, längeres Leben zu ermöglichen. Dank der Kombination von Pharma und Diagnostika unter einem Dach ist Roche führend in der personalisierten Medizin - einer Strategie mit dem Ziel, jeder Patientin und jedem Patienten die bestmögliche Behandlung zukommen zu lassen. Roche ist das grösste Biotech-Unternehmen weltweit mit differenzierten Medikamenten für die Onkologie, Immunologie, Infektionskrankheiten, Augenheilkunde und Erkrankungen des Zentralnervensystems. Roche ist auch der bedeutendste Anbieter von In-vitro-Diagnostika und gewebebasierten Krebstests und ein Pionier im Diabetesmanagement. Seit der Gründung im Jahr 1896 erforscht Roche bessere Wege, um Krankheiten zu verhindern, zu erkennen und zu behandeln und leistet einen nachhaltigen Beitrag zur gesellschaftlichen Entwicklung. Zum Ziel des Unternehmens gehört es durch Kooperationen mit allen relevanten Partnern den Zugang von Patienten zu medizinischen Innovationen zu verbessern. Auf der Liste der unentbehrlichen Arzneimittel der Weltgesundheitsorganisation stehen heute 30 von Roche entwickelte Medikamente, darunter lebensrettende Antibiotika, Malariamittel und Krebsmedikamente. Ausgezeichnet wurde Roche zudem bereits das neunte Jahr in Folge als das nachhaltigste Unternehmen innerhalb der Pharma-, Biotechnologie- und Life-Sciences-Branche im Dow Jones Sustainability Index. Die Roche-Gruppe mit Hauptsitz in Basel, Schweiz ist in über 100 Ländern tätig und beschäftigte 2017 weltweit rund 94 000 Mitarbeiterinnen und Mitarbeiter. Im Jahr 2017 investierte Roche CHF 10,4 Milliarden in Forschung und Entwicklung und erzielte einen Umsatz von CHF 53,3 Milliarden. Genentech in den USA gehört vollständig zur Roche-Gruppe. Roche ist Mehrheitsaktionär von Chugai Pharmaceutical, Japan. Weitere Informationen finden Sie unter www.roche.com/careers #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalizedHealthcare #GreatPlaceToWork #Innovation
- Website
-
http://www.roche.com/
Externer Link zu Roche
- Branche
- Biotechnologieforschung
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- Switzerland 🇨🇭
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Spezialgebiete
- biotechnology, innovation, personalized healthcare, great place to work, diagnostics, pharmaceuticals, research, healthcare, personalised healthcare, diabetes care, genomics, healthcare technology, big data und Science
Orte
Beschäftigte von Roche
Updates
-
Yesterday we opened the doors of the Roche Genentech Innovation Center Boston. At Harvard's Enterprise Research Campus in Allston, 95,000 square feet of new research space is now home to something we've wanted to build for a long time: an end-to-end R&D environment where discovery research, clinical development, AI and data science sit side by side. The focus is to have end-to-end R&D capabilities in cardiovascular, renal and metabolic diseases. These conditions are deeply interconnected in patients, yet science has traditionally studied them separately. Bringing these teams under one roof is our attempt to change that and to pursue more holistic approaches to treatment. A few things that made it meaningful: 🔬 Our first research presence on the U.S. East Coast, complementing our established teams in South San Francisco and Basel. 🤖 AI and machine learning applied to clinical development — including trial design — so we can make better-informed decisions and reach patients faster. 🤝 Capacity for up to 500 people, and a 10-year commitment to the Boston/Cambridge scientific community. Thank you to the state and city leaders, academic partners and colleagues who joined us for the ribbon-cutting — and to everyone across Massachusetts' remarkable life sciences ecosystem who made this possible. The building is open. Now the real work begins.
-
-
🛡️ At Roche, innovation and security go hand in hand. Meet Esteban, our Head of Security Platforms. He and his team architect the seamless protection that allows our scientists to thrive - all while keeping patient data secure. By making the secure path the easiest one to follow, our team empowers developers and researchers to innovate fearlessly. Because they build the frameworks that keep us all safe, life-saving applications can launch globally with confidence. That is digital trust in action.🤝 Interested in Information Security? See how you can be the next in action: 🔗 https://lnkd.in/dwS6kncK #InformationSecurity #CyberSecurity #RocheCareers
-
When we pick up food at the supermarket, we rarely think about everything that happened before it reached the shelf. From safety checks to quality standards, countless decisions happen behind the scenes to protect consumers and shape what we buy. The same is true for medicines and health technologies. The policies behind healthcare don't just affect health systems, they influence the care people can access, the innovations that reach patients and the health of our communities.
-
Today, September 17, marks World Patient Safety Day! 🧡 Under this year’s theme, "Safe care for life!", we’re honoring the everyday resilience of patients and caregivers managing long-term health journeys. Noncommunicable diseases cause nearly 74% of deaths worldwide, representing millions of real lives depending on safe, daily care over a lifetime. The truth is, patient safety isn't just something we work on, it’s something we live. Behind every job title, we are daughters, sons, partners, and parents supporting the people we love through complex health journeys. That’s why ensuring safe care isn't just what we do, it’s deeply personal to every one of us. Watch the video and discover why patient safety is a journey we take together—every day, every dose, every step. #WPSD
-
Cancer research can be a great challenge. Minute biological clues allow researchers to detect and track cancer, but high accuracy and throughput is required to overcome challenges of sample degradation and genomic interference, which can be challenging with existing methods. Sequencing by expansion (SBX) offers a new approach. By converting DNA information into “expanded” synthetic surrogate molecules for high-throughput sequencing, SBX can help researchers better detect tiny traces of circulating tumor DNA (ctDNA). Discover how molecular signals can be transformed into genomic insights: https://lnkd.in/dwQTwJZS (Roche's sequencing technology is currently for research use only.) #Genomics #CancerResearch #NGS #MakeSpaceWithSBX #RocheSBX
-
-
Tomorrow, 17 September, is World Patient Safety Day! 🧡 This year’s theme, "Safe care for life!", highlights the critical need for safe, long-term management of noncommunicable diseases like heart condition, diabetes, and cancer. Managing a long-term condition isn't a single event, it’s an everyday journey across multiple doctors, prescriptions, and home routines. 📄 Swipe through the slides to discover simple ways patients and caregivers can make daily care safer. #WPSD
-
A recently released children’s film generated $312 million at the global box office in its opening weekend. Invested into health, this could generate up to $1.25 billion in economic value. Numbers like these can help put the scale of investments into perspective. Swipe through to see why investing in health innovation benefits us all. #WhatsItWorth #WCC2026 #GlobalHealth
-
Despite significant advances in oncology, unmet needs persist in lymphoma care, and many patients are still considered incurable. For those navigating relapse and treatment resistance, the burden extends far beyond clinical outcomes to everyday quality-of-life challenges: • Access to new treatments • Long treatment waiting times • Transport to specialized treatment centres • The daily psychological toll of disease management Addressing these friction points requires advancing science that directly improves the patient experience at every stage. Through ongoing research and innovation, our commitment remains clear: turning breakthrough science into meaningful advances that elevate standards of care and enable patients to live life beyond their disease. #Lymphoma #BloodAwarenessMonth #HealthcareInnovation #OncologyCare
-
"I think predictive technology gives us a lot more than just a safe sleep and better predictions. It also means more quality of life and not using this energy for the diabetes, but actually using it for things that matter to us." — Michelle Schmidt, diabetes advocate (CEO, Diability GmbH) In a recent survey, 71% of respondents say they often feel tired because of their diabetes, fueled by the constant threat of nighttime lows.* A study showed that night low prediction technology reduced the odds of severe nighttime lows by 31%.* Moving from reactive monitoring to proactive management. Providing valuable foresight when it is needed most.🌙 https://lnkd.in/dazUPVDX * GWI Research Study commissioned by Roche (2025), Diabetes Research and Clinical Practice (2026) #DiabetesCare #DigitalHealth #NightLowPredict #Innovation #Roche